EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Liver-Enriched miR-122 in COVID-19 Patients: A Longitudinal Real-Life Study

Nicoleta Mihai iD, Cătălin Tilișcan, Iulia Virginia Iancu iD, Oana-Alexandra Ganea, Aida-Isabela Adamescu iD, Ștefan Sorin Aramă iD, Andreea Letiția Arsene iD, Simona-Maria Ruță iD, Victoria Aramă

International Journal of Molecular Sciences · 28.02.2026 · 27 (5) · 2288

DOI: 10.3390/ijms27052288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.02.2026. Verfasst von Nicoleta Mihai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: MicroRNAs, Liver, COVID-19. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal liver function tests are frequently reported in patients with COVID-19. This study aimed to identify potential treatment-associated hepatocellular injury in COVID-19 patients by dynamically assessing circulating miR-122, a biomarker with high hepatic specificity and sensitivity. An exploratory approach was additionally used, given the limited evidence regarding factors influencing miR-122 expression in this setting. We performed a prospective cohort study including 96 adult participants enrolled at a tertiary hospital in Bucharest, Romania, between March 2022 and July 2023: 78 COVID-19 patients (57 with baseline and follow-up miR-122 assessment after 5 days of treatment and 21 with a single measurement) and 18 non-COVID-19 participants included for comparison. Plasma miR-122 levels were measured using quantitative polymerase chain reaction, normalized to U6 small nuclear RNA, and expressed as log10(2−ΔCt). No associations were observed between miR-122 expression and remdesivir administered for standard treatment durations (3–5 days) or other COVID-19–specific therapies. However, a duration-dependent relationship with remdesivir cannot be excluded. Moreover, therapeutic paracetamol use prior to presentation was positively associated with miR-122 expression at follow-up and remained significant after adjustment. Additionally, bivariate analyses revealed inverse correlations between baseline miR-122 and inflammatory biomarkers, with multivariable analysis showing an independent positive association with lymphocyte count.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLiverCOVID-19HumansMaleFemaleMiddle AgedBiomarkersAdenosine MonophosphateAlanineProspective StudiesAntiviral AgentsLongitudinal StudiesSARS-CoV-2AcetaminophenCOVID-19 Drug TreatmentAdultAged

Stichwörter der Autor:innen

COVID-19drug-induced liver injurymiR-122paracetamolremdesivirsystemic inflammation

Substanzen

MicroRNAsMIRN122 microRNA, humanBiomarkersremdesivirAdenosine MonophosphateAlanineAntiviral AgentsAcetaminophen

Autor:innen und Institutionen

  • Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania.
  • "Prof. Dr. Matei Balș" National Institute for Infectious Diseases, 1 Calistrat Grozovici Street, 021105 Bucharest, Romania.
  • Faculty of Dental Medicine, "Carol Davila" University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania.
  • "Ştefan S. Nicolau" Institute of Virology, 285 Mihai Bravu Road, 030304 Bucharest, Romania.
  • Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021 Bucharest, Romania.

ORCID-Profile: Nicoleta Mihai, Iulia Virginia Iancu, Aida-Isabela Adamescu, Ștefan Sorin Aramă, Andreea Letiția Arsene, Simona-Maria Ruță

Zitieren

APA

Mihai, N., Tilișcan, C., Iancu, I. V., Ganea, O. A., Adamescu, A. I., Aramă, Ș. S., Arsene, A. L., Ruță, S. M., & Aramă, V. (2026). Circulating Liver-Enriched miR-122 in COVID-19 Patients: A Longitudinal Real-Life Study. International Journal of Molecular Sciences, 27(5), 2288. https://doi.org/10.3390/ijms27052288

Vancouver

Mihai N, Tilișcan C, Iancu IV, Ganea OA, Adamescu AI, Aramă ȘS, et al. Circulating Liver-Enriched miR-122 in COVID-19 Patients: A Longitudinal Real-Life Study. International Journal of Molecular Sciences. 2026;27(5):2288. doi:10.3390/ijms27052288

BibTeX
@article{Mihai2026,
  author = {Mihai, Nicoleta and Tilișcan, Cătălin and Iancu, Iulia Virginia and Ganea, Oana-Alexandra and Adamescu, Aida-Isabela and Aramă, Ștefan Sorin and Arsene, Andreea Letiția and Ruță, Simona-Maria and Aramă, Victoria},
  title = {Circulating Liver-Enriched miR-122 in COVID-19 Patients: A Longitudinal Real-Life Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2288},
  doi = {10.3390/ijms27052288}
}
Kostenlos starten →